Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Hypertension

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Hypertension in 2 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, D1
Ren, J1
Gillespie, DG1
Mi, Z1
Jackson, EK1
Kobrin, I1
Ebstein, R1
Ben-Ishay, D1

Other Studies

2 other studies available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Hypertension

ArticleYear
Regulation of 3',5'-cAMP in preglomerular smooth muscle and endothelial cells from genetically hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adrenergic beta-Agonist

2010
Cyclic AMP generation in hypothalamus of hypertension-prone and -resistant rats.
    Clinical science (London, England : 1979), 1980, Volume: 59 Suppl 6

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Cyclic AMP; Hypertension; Hypothalamus; In

1980